Support Via Online Social Networks to Promote Safe Infant Care Practices
Launched by UNIVERSITY OF VIRGINIA · Mar 2, 2023
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how online social networks, like private Facebook groups, can help new and expectant mothers follow safe sleep practices for their babies and improve breastfeeding rates. The goal is to provide helpful information and create a supportive community for women who are pregnant and enrolled in the WIC program, which helps low-income families. By sharing videos and educational resources, the trial aims to reduce differences in these parenting practices between Black and White families.
To be eligible for the study, you must be a pregnant woman who is less than 30 weeks along, lives in the United States, speaks English, and has access to Facebook and texting. You should also be enrolled in the WIC program or have Medicaid or no health insurance. If you join, you can expect to participate in a supportive online community where you can learn and share experiences with others. It's important to note that certain factors, like not planning to live with your baby after birth or specific health issues, may prevent you from participating.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Currently enrolled in WIC, or it not, then have either Medicaid or no health insurance
- • Must be English speaking
- • Must be pregnant and less than 30 weeks gestation
- • Must live in the United States
- • Must have regular access to Facebook and short message service (SMS) texting (mobile phone)
- Exclusion Criteria:
- • Not planning to live in same home as infant after birth.
- • Prenatal diagnosis expected to impact on infant care practices in a manner not compatible with study goals, including contraindications to feeding any breastmilk or supine infant sleep positioning.
- • Known or reported mental health or other issues that would preclude custody of the infant or being able to participate in the informed consent process.
- • Meets the definition of a minor according to applicable state law.
- • Participants who consent to participation in the study, must complete the Agile Onboarding process before they reach 30+0 weeks gestation.
- • Currently or previously received a TodaysBaby educational program (randomized to a TodaysBaby program through either the SMARTER, or SUPERSONIC study), either in their current or a previous pregnancy.
About University Of Virginia
The University of Virginia (UVA) is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, UVA leverages its extensive resources and expertise in various fields, including medicine, engineering, and public health, to drive cutting-edge studies that address pressing health challenges. The university's clinical trial programs aim to translate scientific discoveries into effective treatments, ensuring the highest standards of ethical practice and participant safety. Through its strong emphasis on community engagement and education, UVA fosters a culture of research that not only contributes to the scientific community but also enhances the well-being of the populations it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Rachel Y Moon, MD
Principal Investigator
University of Virginia School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials